Benchmark analyst Kenneth Bruce reiterates Harvard Bioscience (NASDAQ:HBIO) with a Buy and maintains $4 price target.
The AYRO Vanish Enters Production Readiness Review
Process will determine readiness of the low-speed EV for production
ROUND ROCK, TX / ACCESSWIRE / June 28, 2023 / AYRO, Inc. (NASDAQ:AYRO) ("AYRO" or the "Company"), a designer and manufacturer